APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antihypertensive Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antihypertensive Drugs Industry Growth and Trends Forecast to 2032

20 December 2025107 pages

Choose your research edition.

Industry ResearchAntihypertensive Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Antihypertensive Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antihypertensive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antihypertensive Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Antihypertensive Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Antihypertensive Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antihypertensive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antihypertensive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antihypertensive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antihypertensive Drugs include Takeda, Sanofi, Johnson & Johnson, Novartis, Merck, Pfizer, United Therapeutics, Ranbaxy Laboratories and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antihypertensive Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antihypertensive Drugs market size, estimates, and forecasts are presented in terms of sales volume (M Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antihypertensive Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antihypertensive Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antihypertensive Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antihypertensive Drugs Market by Company

Takeda

Sanofi

Johnson & Johnson

Novartis

Merck

Pfizer

United Therapeutics

Ranbaxy Laboratories

Lupin

Daiichi Sankyo

Astra Zeneca

Actelion

Antihypertensive Drugs Segment by Type

Calcium Antagonist Medicine

Sympathetic Suppressant

Diuretic Antihypertensive

Renin-angiotensin System Inhibitor

vasodilator

Antihypertensive Drugs Segment by Application

Pregnant Woman

General Patient

The Old

Antihypertensive Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihypertensive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antihypertensive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihypertensive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antihypertensive Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antihypertensive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Calcium Antagonist Medicine Table 2. Major Company of Sympathetic Suppressant Table 3. Major Company of Diuretic Antihypertensive Table 4. Major Company of Renin-angiotensin System Inhibitor Table 5. Major Company of vasodilator Table 6. Global Antihypertensive Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs) Table 8. Global Antihypertensive Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Antihypertensive Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Antihypertensive Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Antihypertensive Drugs Price by Type (2021-2026) & (US$/Pcs) Table 12. Global Antihypertensive Drugs Sales by Type (2027-2032) & (M Pcs) Table 13. Global Antihypertensive Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Antihypertensive Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Antihypertensive Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Antihypertensive Drugs Price by Type (2027-2032) & (US$/Pcs) Table 17. North America Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs) Table 18. North America Antihypertensive Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs) Table 20. Europe Antihypertensive Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs) Table 22. Asia-Pacific Antihypertensive Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs) Table 24. Latin America Antihypertensive Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs) Table 26. Middle East and Africa Antihypertensive Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Antihypertensive Drugs Industry Trends Table 28. Antihypertensive Drugs Industry Drivers Table 29. Antihypertensive Drugs Industry Opportunities and Challenges Table 30. Antihypertensive Drugs Industry Restraints Table 31. Global Antihypertensive Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Antihypertensive Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Antihypertensive Drugs Sales by Company (2021-2026) & (M Pcs) Table 34. Global Antihypertensive Drugs Sales Share by Company (2021-2026) Table 35. Global Antihypertensive Drugs Market Price by Company (2021-2026) & (US$/Pcs) Table 36. Global Antihypertensive Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Antihypertensive Drugs Major Company Production Sites and Headquarters Table 38. Global Antihypertensive Drugs Company, Product Type & Application Table 39. Global Antihypertensive Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Antihypertensive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Antihypertensive Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Antihypertensive Drugs Sales by Region (2021-2026) & (M Pcs) Table 44. Global Antihypertensive Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Antihypertensive Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Antihypertensive Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Antihypertensive Drugs Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 48. Global Antihypertensive Drugs Sales by Region (2027-2032) & (M Pcs) Table 49. Global Antihypertensive Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Antihypertensive Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Antihypertensive Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Antihypertensive Drugs Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 53. Global Antihypertensive Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs) Table 55. Global Antihypertensive Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Antihypertensive Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Antihypertensive Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Antihypertensive Drugs Price by Application (2021-2026) & (US$/Pcs) Table 59. Global Antihypertensive Drugs Sales by Application (2027-2032) & (M Pcs) Table 60. Global Antihypertensive Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Antihypertensive Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Antihypertensive Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Antihypertensive Drugs Price by Application (2027-2032) & (US$/Pcs) Table 64. North America Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs) Table 65. North America Antihypertensive Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs) Table 67. Europe Antihypertensive Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs) Table 69. Asia-Pacific Antihypertensive Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs) Table 71. Latin America Antihypertensive Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs) Table 73. Middle East and Africa Antihypertensive Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Takeda Company Information Table 75. Takeda Business Overview Table 76. Takeda Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 77. Takeda Antihypertensive Drugs Product Portfolio Table 78. Takeda Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 82. Sanofi Antihypertensive Drugs Product Portfolio Table 83. Sanofi Recent Development Table 84. Johnson & Johnson Company Information Table 85. Johnson & Johnson Business Overview Table 86. Johnson & Johnson Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 87. Johnson & Johnson Antihypertensive Drugs Product Portfolio Table 88. Johnson & Johnson Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 92. Novartis Antihypertensive Drugs Product Portfolio Table 93. Novartis Recent Development Table 94. Merck Company Information Table 95. Merck Business Overview Table 96. Merck Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 97. Merck Antihypertensive Drugs Product Portfolio Table 98. Merck Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 102. Pfizer Antihypertensive Drugs Product Portfolio Table 103. Pfizer Recent Development Table 104. United Therapeutics Company Information Table 105. United Therapeutics Business Overview Table 106. United Therapeutics Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 107. United Therapeutics Antihypertensive Drugs Product Portfolio Table 108. United Therapeutics Recent Development Table 109. Ranbaxy Laboratories Company Information Table 110. Ranbaxy Laboratories Business Overview Table 111. Ranbaxy Laboratories Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 112. Ranbaxy Laboratories Antihypertensive Drugs Product Portfolio Table 113. Ranbaxy Laboratories Recent Development Table 114. Lupin Company Information Table 115. Lupin Business Overview Table 116. Lupin Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 117. Lupin Antihypertensive Drugs Product Portfolio Table 118. Lupin Recent Development Table 119. Daiichi Sankyo Company Information Table 120. Daiichi Sankyo Business Overview Table 121. Daiichi Sankyo Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 122. Daiichi Sankyo Antihypertensive Drugs Product Portfolio Table 123. Daiichi Sankyo Recent Development Table 124. Astra Zeneca Company Information Table 125. Astra Zeneca Business Overview Table 126. Astra Zeneca Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 127. Astra Zeneca Antihypertensive Drugs Product Portfolio Table 128. Astra Zeneca Recent Development Table 129. Actelion Company Information Table 130. Actelion Business Overview Table 131. Actelion Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 132. Actelion Antihypertensive Drugs Product Portfolio Table 133. Actelion Recent Development Table 134. North America Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 135. North America Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs) Table 136. North America Antihypertensive Drugs Sales Market Share by Country (2021-2026) Table 137. North America Antihypertensive Drugs Sales Forecast by Country (2027-2032) & (M Pcs) Table 138. North America Antihypertensive Drugs Sales Market Share Forecast by Country (2027-2032) Table 139. North America Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. North America Antihypertensive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 141. North America Antihypertensive Drugs Market Share by Country (2021-2026) Table 142. North America Antihypertensive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. North America Antihypertensive Drugs Market Share Forecast by Country (2027-2032) Table 144. Europe Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 145. Europe Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs) Table 146. Europe Antihypertensive Drugs Sales Market Share by Country (2021-2026) Table 147. Europe Antihypertensive Drugs Sales Forecast by Country (2027-2032) & (M Pcs) Table 148. Europe Antihypertensive Drugs Sales Market Share Forecast by Country (2027-2032) Table 149. Europe Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Europe Antihypertensive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 151. Europe Antihypertensive Drugs Market Share by Country (2021-2026) Table 152. Europe Antihypertensive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Europe Antihypertensive Drugs Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs) Table 156. Asia-Pacific Antihypertensive Drugs Sales Market Share by Country (2021-2026) Table 157. Asia-Pacific Antihypertensive Drugs Sales Forecast by Country (2027-2032) & (M Pcs) Table 158. Asia-Pacific Antihypertensive Drugs Sales Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Antihypertensive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 161. Asia-Pacific Antihypertensive Drugs Market Share by Country (2021-2026) Table 162. Asia-Pacific Antihypertensive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Asia-Pacific Antihypertensive Drugs Market Share Forecast by Country (2027-2032) Table 164. Latin America Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 165. Latin America Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs) Table 166. Latin America Antihypertensive Drugs Sales Market Share by Country (2021-2026) Table 167. Latin America Antihypertensive Drugs Sales Forecast by Country (2027-2032) & (M Pcs) Table 168. Latin America Antihypertensive Drugs Sales Market Share Forecast by Country (2027-2032) Table 169. Latin America Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Latin America Antihypertensive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 171. Latin America Antihypertensive Drugs Market Share by Country (2021-2026) Table 172. Latin America Antihypertensive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Latin America Antihypertensive Drugs Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs) Table 176. Middle East and Africa Antihypertensive Drugs Sales Market Share by Country (2021-2026) Table 177. Middle East and Africa Antihypertensive Drugs Sales Forecast by Country (2027-2032) & (M Pcs) Table 178. Middle East and Africa Antihypertensive Drugs Sales Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Antihypertensive Drugs Market Size by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa Antihypertensive Drugs Market Share by Country (2021-2026) Table 182. Middle East and Africa Antihypertensive Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Middle East and Africa Antihypertensive Drugs Market Share Forecast by Country (2027-2032) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Antihypertensive Drugs Distributors List Table 187. Antihypertensive Drugs Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Antihypertensive Drugs Image Figure 2. Global Antihypertensive Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antihypertensive Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Antihypertensive Drugs Sales (2021-2032) & (M Pcs) Figure 5. Calcium Antagonist Medicine Image Figure 6. Global Calcium Antagonist Medicine Sales YoY Growth (2021-2032) & (M Pcs) Figure 7. Sympathetic Suppressant Image Figure 8. Global Sympathetic Suppressant Sales YoY Growth (2021-2032) & (M Pcs) Figure 9. Diuretic Antihypertensive Image Figure 10. Global Diuretic Antihypertensive Sales YoY Growth (2021-2032) & (M Pcs) Figure 11. Renin-angiotensin System Inhibitor Image Figure 12. Global Renin-angiotensin System Inhibitor Sales YoY Growth (2021-2032) & (M Pcs) Figure 13. vasodilator Image Figure 14. Global vasodilator Sales YoY Growth (2021-2032) & (M Pcs) Figure 15. Global Antihypertensive Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Antihypertensive Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Antihypertensive Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Antihypertensive Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Antihypertensive Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Antihypertensive Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Antihypertensive Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Antihypertensive Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Antihypertensive Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Antihypertensive Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Antihypertensive Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Antihypertensive Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Antihypertensive Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Pregnant Woman Image Figure 30. Global Pregnant Woman Sales YoY Growth (2021-2032) & (M Pcs) Figure 31. General Patient Image Figure 32. Global General Patient Sales YoY Growth (2021-2032) & (M Pcs) Figure 33. The Old Image Figure 34. Global The Old Sales YoY Growth (2021-2032) & (M Pcs) Figure 35. Global Antihypertensive Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Antihypertensive Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Antihypertensive Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Antihypertensive Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Antihypertensive Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Antihypertensive Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Antihypertensive Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Antihypertensive Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Antihypertensive Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Antihypertensive Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Antihypertensive Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Antihypertensive Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Antihypertensive Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 48. North America Antihypertensive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Antihypertensive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Antihypertensive Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 52. Europe Antihypertensive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Antihypertensive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Antihypertensive Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 56. Asia-Pacific Antihypertensive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Antihypertensive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Antihypertensive Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 60. Latin America Antihypertensive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Antihypertensive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Antihypertensive Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 64. Middle East and Africa Antihypertensive Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Antihypertensive Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Antihypertensive Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Antihypertensive Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Calcium Antagonist Medicine
  • Sympathetic Suppressant
  • Diuretic Antihypertensive
  • Renin-angiotensin System Inhibitor
  • vasodilator
Applications
  • Pregnant Woman
  • General Patient
  • The Old
Companies covered
  • Takeda
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Pfizer
  • United Therapeutics
  • Ranbaxy Laboratories
  • Lupin
  • Daiichi Sankyo
  • Astra Zeneca
  • Actelion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antihypertensive Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antihypertensive Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antihypertensive Drugs Market by Type
  6. 1.3.1 Calcium Antagonist Medicine
  7. 1.3.2 Sympathetic Suppressant
  8. 1.3.3 Diuretic Antihypertensive
  9. 1.3.4 Renin-angiotensin System Inhibitor
  10. 1.3.5 vasodilator
  11. 1.4 Global Antihypertensive Drugs Market Size by Type
  12. 1.4.1 Global Antihypertensive Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Antihypertensive Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Antihypertensive Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Antihypertensive Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Antihypertensive Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Antihypertensive Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Antihypertensive Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Antihypertensive Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antihypertensive Drugs Industry Trends
  2. 2.2 Antihypertensive Drugs Industry Drivers
  3. 2.3 Antihypertensive Drugs Industry Opportunities and Challenges
  4. 2.4 Antihypertensive Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antihypertensive Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Antihypertensive Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Antihypertensive Drugs Price (2021-2026)
  4. 3.4 Global Antihypertensive Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antihypertensive Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Antihypertensive Drugs Company, Product Type & Application
  7. 3.7 Global Antihypertensive Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antihypertensive Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antihypertensive Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antihypertensive Drugs Tier 1, Tier 2, and Tier 3
4 Antihypertensive Drugs Regional Status and Outlook
  1. 4.1 Global Antihypertensive Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antihypertensive Drugs Historic Market Size by Region
  3. 4.2.1 Global Antihypertensive Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antihypertensive Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antihypertensive Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antihypertensive Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Antihypertensive Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antihypertensive Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antihypertensive Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antihypertensive Drugs by Application
  1. 5.1 Antihypertensive Drugs Market by Application
  2. 5.1.1 Pregnant Woman
  3. 5.1.2 General Patient
  4. 5.1.3 The Old
  5. 5.2 Global Antihypertensive Drugs Market Size by Application
  6. 5.2.1 Global Antihypertensive Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antihypertensive Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antihypertensive Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antihypertensive Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antihypertensive Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antihypertensive Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antihypertensive Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antihypertensive Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Antihypertensive Drugs Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Antihypertensive Drugs Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Antihypertensive Drugs Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Antihypertensive Drugs Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Antihypertensive Drugs Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Antihypertensive Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 United Therapeutics
  38. 6.7.1 United Therapeutics Company Information
  39. 6.7.2 United Therapeutics Business Overview
  40. 6.7.3 United Therapeutics Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 United Therapeutics Antihypertensive Drugs Product Portfolio
  42. 6.7.5 United Therapeutics Recent Developments
  43. 6.8 Ranbaxy Laboratories
  44. 6.8.1 Ranbaxy Laboratories Company Information
  45. 6.8.2 Ranbaxy Laboratories Business Overview
  46. 6.8.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ranbaxy Laboratories Antihypertensive Drugs Product Portfolio
  48. 6.8.5 Ranbaxy Laboratories Recent Developments
  49. 6.9 Lupin
  50. 6.9.1 Lupin Company Information
  51. 6.9.2 Lupin Business Overview
  52. 6.9.3 Lupin Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lupin Antihypertensive Drugs Product Portfolio
  54. 6.9.5 Lupin Recent Developments
  55. 6.10 Daiichi Sankyo
  56. 6.10.1 Daiichi Sankyo Company Information
  57. 6.10.2 Daiichi Sankyo Business Overview
  58. 6.10.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Daiichi Sankyo Antihypertensive Drugs Product Portfolio
  60. 6.10.5 Daiichi Sankyo Recent Developments
  61. 6.11 Astra Zeneca
  62. 6.11.1 Astra Zeneca Company Information
  63. 6.11.2 Astra Zeneca Business Overview
  64. 6.11.3 Astra Zeneca Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Astra Zeneca Antihypertensive Drugs Product Portfolio
  66. 6.11.5 Astra Zeneca Recent Developments
  67. 6.12 Actelion
  68. 6.12.1 Actelion Company Information
  69. 6.12.2 Actelion Business Overview
  70. 6.12.3 Actelion Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Actelion Antihypertensive Drugs Product Portfolio
  72. 6.12.5 Actelion Recent Developments
7 North America by Country
  1. 7.1 North America Antihypertensive Drugs Sales by Country
  2. 7.1.1 North America Antihypertensive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antihypertensive Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Antihypertensive Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antihypertensive Drugs Market Size by Country
  6. 7.2.1 North America Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antihypertensive Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Antihypertensive Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antihypertensive Drugs Sales by Country
  2. 8.1.1 Europe Antihypertensive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antihypertensive Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Antihypertensive Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antihypertensive Drugs Market Size by Country
  6. 8.2.1 Europe Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antihypertensive Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antihypertensive Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antihypertensive Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Antihypertensive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antihypertensive Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antihypertensive Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antihypertensive Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antihypertensive Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antihypertensive Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antihypertensive Drugs Sales by Country
  2. 10.1.1 South America Antihypertensive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antihypertensive Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Antihypertensive Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antihypertensive Drugs Market Size by Country
  6. 10.2.1 South America Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antihypertensive Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Antihypertensive Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antihypertensive Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Antihypertensive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antihypertensive Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antihypertensive Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antihypertensive Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Antihypertensive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antihypertensive Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antihypertensive Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antihypertensive Drugs Value Chain Analysis
  2. 12.1.1 Antihypertensive Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antihypertensive Drugs Production Mode & Process
  7. 12.2 Antihypertensive Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antihypertensive Drugs Distributors
  10. 12.2.3 Antihypertensive Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst